Avidity Biosciences' Series B Round

Avidity Biosciences raised a round of funding on January 05, 2017.

Avidity Biosciences, formerly Avidity NanoMedicines, is a privately held biotech company pioneering a new class of precision medicines – Antibody-siRNA Conjugates (ASC) – which combine the strengt…

Articles about Avidity Biosciences' Series B Round: